AstraZeneca PLC (AZN)
NYSE
Healthcare
Drug Manufacturers - General
$178.49
▼ -5.70%
Market Cap
$276.82B
Sector
Healthcare
Industry
Drug Manufacturers - General
Beta
0.23
52-Wk Range
137.22-212.71
CEO
Pascal Claude Roland Soriot
Country
GB
Currency
USD
AstraZeneca PLC operates as a global biopharmaceutical leader, dedicated to the entire process of bringing prescription medicines to market, from their initial discovery and development through manufacturing and commercialization. The company's extensive portfolio of treatments, including prominent examples like Tagrisso, Farxiga, and Symbicort, addresses critical areas such as cardiovascular, renal, metabolic, and oncological conditions. Furthermore, it provides essential solutions for COVID-19 and various rare diseases, with products like Vaxzevria and Soliris. AstraZeneca engages with prima…
Open full interactive analysis & DCF →